PCI-32765 (Racemate) is a chemical compound that functions as a Bruton tyrosine kinase inhibitor. It is an aromatic ether with a complex structure containing multiple ring systems, an amide group, and an amine group, and it is used as a pharmaceutical raw material in manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing PCI-32765 (Racemate)?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ibrutinib acetyl impurity
pharmaceutical impurity standard
(R)-tert-Butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate
pharmaceutical raw material
Rilzabrutinib, (Z)-
pharmaceutical raw material
Tolebrutinib
pharmaceutical raw material
Tucatinib
pharmaceutical raw material
Pacritinib
pharmaceutical raw material
D-Pemetrexed disodium
pharmaceutical raw material
Roxatidine acetate hydrochloride
pharmaceutical raw material
1-[3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
XYFPWWZEPKGCCK-UHFFFAOYSA-N
C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N
Sourcing PCI-32765 (Racemate)?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.